Trial Profile
Phase 3 Study of Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Respiratory tract infections
- Focus Registrational; Therapeutic Use
- 12 Jan 2012 New trial record